The stock market debut of Arm Holdings (ARM.US) is reverberating through the financial press and is once again electrifying the artificial intelligence sector. Today is the debut day on the Nasdaq but a rebalancing is currently underway with the opening price still being determined. Last year, the company was unsuccessfully tried to be acquired by Nvidia (NVDA.US), and UK Prime Minister Rishi Sunak sought its return to the floor of the London Stock Exchange. In the end, its listing will take off on the Nasdaq today, with a valuation of $54.5 billion, indicating that this is the largest IPO in more than two years, when EV maker Rivian (RIVN.US) was valued at more than $66 billion.
The idea behind the IPO
Japan's SoftBank, known for its strong exposure to the technology sector, is behind the company's listing on the Nasdaq. The British Arm company is the largest designer of chips for smartphones and could potentially benefit from a wave of interest in new AI capabilities. Currently, chips designed by the company are present in most smartphones in the world including iPhones. The company itself was founded in 1990 as a joint venture between Acorn Computers, Apple and VLSI. It was listed on the London Stock Exchange and Nasdaq from 1998 until 2016, when SoftBank acquired Arm for $32 billion, taking it off the exchange. After rejecting Nvidia's offer, the company is conducting an IPO.
Start investing today or test a free demoOpen real account TRY DEMO Download mobile app Download mobile app
What is Arm known for?
Primarily for designing and manufacturing chips for smartphones but the company has ambitions to become a competitor to Nvidia in the AI chip market.
- Arm's biggest customers include technology giants such as Apple (AAPL.US), which in early September decided to extend a long-term chip supply agreement from the British giant
- The company designs and manufactures chips for most of the world's smartphones. It is estimated that its products are used in up to 95% of all modern phones
- The company is working to expand beyond the smartphone market, which has been stagnating. The target for Arm is becoming more advanced chips, particularly chips for data centers and generative AI applications. This is where the company sees its opportunities;
- Arm claims that the processors it designs will accelerate the development of artificial intelligence and machine learning allogrithms. Arm has already begun adding new features to make the algorithms run faster and is creating viable solutions for the chip market;
- Speculation from the tech sector indicates that a potentially successful IPO could be a catalyst for dozens of tech startups.
Is valuation too high?
- The IPO share price has been set at $51. The sale of 95.5 million shares will generate about $4.87 billion in profit for Softbank. Market reports originally suggested a higher IPO price, but the banks were said to have convinced Softbank to lower it in order to stimulate demand on the day of the debut;
- However, there are elements of risk in the background. Some market analysts are questioning the company's initial valuation, noting that it is 36% higher than the $40 billion initial takeover bid by Nvidia last year. On the other hand, however, at the time of Softbank's deal with Vision Fund, Arm was valued at $64 billion;
- The company's ability to grow has been questioned in particular, as it has recently experienced a decline in revenue due to weaker smartphone sales. Sales results for the fiscal year ended March 2023 were about 1% worse compared to the previous period
- Arm has set aside more than $700 million in shares as part of the IPO so that it can be bought back by the company's biggest customers such as Apple Nvidia, Samsung and the world's largest chipmaker TSMC, which intends to invest $100 million in the company;
- Since 90% of the shares are owned by SoftBank, which is listing the company, the new shareholders will not have a decisive influence on the company's policies. At the same time, however, the low free float (the number of shares available for trading) should support a possible price increase.
Arm says research and development is the company's lifeblood and spends more than 42% of its expenses on it. Only two companies in the S&P 500 index - drugmakers Incyte (INCY.US) and Merck (MRK.US) - devote that much to R&D. Among the semiconductor market leaders, the ratio of R&D spending to sales is: for Nvidia, 24%, and Intel, 31%. Source: SEC
Artificial intelligence - the opportunity for strong growth?
- The company is not producing chips for complex AI tasks at this point, but does not rule out such development in the future. Nevertheless, at this point it is already quite a lag compared to Nvidia, which already has products designed for AI-related processing
- The company to gain market share would have to compete primarily on price, which could ultimately provide some respite for companies currently 'doomed' to the dominance of Nvidia chips. Arm's base business appears highly cyclical and uncertain amid the risk of a recession in 2024. According to Counterpoint Research, smartphone shipments in the global market in Q2 totaled 294.5 million compared to 268 million in Q1.
Arm's IPO is one of the most important events in the technology market this year and offers investors a chance to benefit from the growth of the semiconductor sector. However, the investment also comes with high risk and uncertainty, as competition in this market is quite high. It is worth noting that it is not always the case that a technology company gains with the emergence of a new trend in the market. An example is the recent strong rise in the price of Nvidia shares and the rather weak behavior of Intel shares.
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.